Furthermore, pharmacological interventions, namely, angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, and antiplatelet agents, are effective in secondary prevention and mitigation of adverse cardiac events post-MI [6]. Here, ACE is linked to myocardial infarction.